A diseased bone marrow fuels atherosclerosis in diabetes

Atherosclerosis

Volumn 226, Issue 2, 2013, Pages 337-338

  Fadini, Gian Paolo ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

Author keywords

Apolipoprotein E; Neointima hyperplasia; Smooth muscle; Stem cells

Indexed keywords

APOLIPOPROTEIN E;

ATHEROSCLEROSIS; BONE MARROW; BONE MARROW CELL; CELL DIFFERENTIATION; CELL MIGRATION; DIABETES MELLITUS; ENDOTHELIAL PROGENITOR CELL; INHIBITION KINETICS; NONHUMAN; NOTE; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; SMOOTH MUSCLE FIBER;

ANIMALS; ATHEROSCLEROSIS; DIABETES MELLITUS, EXPERIMENTAL; MALE; MYOCYTES, SMOOTH MUSCLE;

EID: 84872417518     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.11.015     Document Type: Note

References (24)

1. Avogaro A., de Kreutzenberg S.V., Fadini G. Endothelial dysfunction: causes and consequences in patients with diabetes mellitus. Diabetes Res Clin Pract 2008, 82(Suppl. 2):S94-S101.
2. Avogaro A., de Kreutzenberg S.V., Fadini G.P. Oxidative stress and vascular disease in diabetes: is the dichotomization of insulin signaling still valid?. Free Radic Biol Med 2008, 44:1209-1215.
3. Menegazzo L., Albiero M., Avogaro A., Fadini G.P. Endothelial progenitor cells in diabetes mellitus. Biofactors 2012, 38:194-202.
4. Fadini G.P. An underlying principle for the study of circulating progenitor cells in diabetes and its complications. Diabetologia 2008, 51:1091-1094.
5. Oikawa A., Siragusa M., Quaini F., et al. Diabetes mellitus induces bone marrow microangiopathy. Arterioscler Thromb Vasc Biol 2010, 30:498-508.
6. Fadini G.P., Albiero M., Vigili de Kreutzenberg S., et al. Diabetes impairs stem cell and proangiogenic cell mobilization in humans. Diabetes Care 2012.
7. Fadini G.P., Avogaro A. It is all in the blood: the multifaceted contribution of circulating progenitor cells in diabetic complications. Exp Diabetes Res 2012, 2012:742976.
8. Fadini G.P., Albiero M., Menegazzo L., et al. Widespread increase in myeloid calcifying cells contributes to ectopic vascular calcification in type 2 diabetes. Circ Res 2011, 108:1112-1121.
9. Fadini G.P., Mancuso P., Bertolini F., de Kreutzenberg S., Avogaro A. Amelioration of glucose control mobilizes circulating pericyte progenitor cells in type 2 diabetic patients with microangiopathy. Exp Diabetes Res 2012, 2012:274363.
10. Fledderus J.O., van Oostrom O., de Kleijn D.P.V., et al. Increased amount of bone marrow-derived smooth muscle-like cells and accelerated atherosclerosis in diabetic apoE-deficient mice. Atherosclerosis 2013, 226(2):341-347.
11. Bentzon J.F., Sondergaard C.S., Kassem M., Falk E. Smooth muscle cells healing atherosclerotic plaque disruptions are of local, not blood, origin in apolipoprotein E knockout mice. Circulation 2007, 116:2053-2061.
12. Bentzon J.F., Weile C., Sondergaard C.S., et al. Smooth muscle cells in atherosclerosis originate from the local vessel wall and not circulating progenitor cells in ApoE knockout mice. Arterioscler Thromb Vasc Biol 2006, 26:2696-2702.
13. Yu H., Stoneman V., Clarke M., et al. Bone marrow-derived smooth muscle-like cells are infrequent in advanced primary atherosclerotic plaques but promote atherosclerosis. Arterioscler Thromb Vasc Biol 2011, 31:1291-1299.
14. Xu Q., Wang J., He J., et al. Impaired CXCR4 expression and cell engraftment of bone marrow-derived cells from aged atherogenic mice. Atherosclerosis 2011, 219:92-99.
15. Murphy A.J., Akhtari M., Tolani S., et al. ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice. J Clin Invest 2011, 121:4138-4149.
16. Westerterp M., Gourion-Arsiquaud S., Murphy A.J., et al. Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol efflux pathways. Cell Stem Cell 2012, 11:195-206.
17. Sakai Y., Kim D.K., Iwasa S., et al. Bone marrow chimerism prevents atherosclerosis in arterial walls of mice deficient in apolipoprotein E. Atherosclerosis 2002, 161:27-34.
18. Sata M., Saiura A., Kunisato A., et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002, 8:403-409.
19. Albiero M., Menegazzo L., Fadini G.P. Circulating smooth muscle progenitors and atherosclerosis. Trends Cardiovasc Med 2010, 20:133-140.
20. Nguyen T.Q., Chon H., van Nieuwenhoven F.A., et al. Myofibroblast progenitor cells are increased in number in patients with type 1 diabetes and express less bone morphogenetic protein 6: a novel clue to adverse tissue remodelling?. Diabetologia 2006, 49:1039-1048.
21. Loomans C.J., van Haperen R., Duijs J.M., et al. Differentiation of bone marrow-derived endothelial progenitor cells is shifted into a proinflammatory phenotype by hyperglycemia. Mol Med 2009, 15:152-159.
22. Fadini G.P., Albiero M., Menegazzo L., et al. Procalcific phenotypic drift of circulating progenitor cells in type 2 diabetes with coronary artery disease. Exp Diabetes Res 2012, 2012:921685.
23. Fadini G.P., Tjwa M. A role for TGF-beta in transforming endothelial progenitor cells into neointimal smooth muscle cells. Atherosclerosis 2010, 211:32-35.
24. Dutta P., Courties G., Wei Y., et al. Myocardial infarction accelerates atherosclerosis. Nature 2012, 487:325-329.